How do I subscribe to ongoing alerts?

Subscribe to /feed/company/international-centre-for-diarrhoeal-disease-research-bangladesh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

International Centre for Diarrhoeal Disease Research, Bangladesh — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

International Centre for Diarrhoeal Disease Research, Bangladesh pipeline: 20 marketed, 0 filed, 7 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

20 marketed 0 filed 7 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Bivalent OPV 4 week interval	Bivalent OPV 4 week interval	marketed
polio vaccines: nOPV2, bOPV, IPV	polio vaccines: nOPV2, bOPV, IPV	marketed
Quadrivalent Influenza Vaccine	Quadrivalent Influenza Vaccine	marketed	Inactivated vaccine	Influenza viruses	Immunology
Fractional IPV( fIPV)	Fractional IPV( fIPV)	marketed	Vaccine		Immunology / Infectious Disease
Monovalent OPV 4 week interval	Monovalent OPV 4 week interval	marketed
Hypo-osmolar ORS	Hypo-osmolar ORS	marketed
JE vaccine new plant lot 3	JE vaccine new plant lot 3	marketed
Bivalent OPV 2 week interval	Bivalent OPV 2 week interval	marketed	vaccine		Immunology
Rotavirus Vaccine (ROTARIX)	Rotavirus Vaccine (ROTARIX)	marketed	Live attenuated vaccine		Immunology / Infectious Disease
Pentavalent vaccine	Pentavalent vaccine	marketed
Monovalent OPV 2 week interval	Monovalent OPV 2 week interval	marketed
JE Vaccine existing facility	JE Vaccine existing facility	marketed	Vaccine	Japanese encephalitis virus envelope proteins	Infectious Disease / Immunology

Therapeutic area mix

Immunology / Infectious Disease · 6
Immunology · 6
Other · 2
Infectious Disease / Immunology · 2
Infectious Diseases · 2
Cardiovascular · 1
Gastroenterology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sinovac Biotech Co., Ltd · 4 shared drug classes
Sanofi Pasteur, a Sanofi Company · 4 shared drug classes
Sanofi · 3 shared drug classes
Merck Sharp & Dohme LLC · 3 shared drug classes
Jiangsu Province Centers for Disease Control and Prevention · 3 shared drug classes
Pfizer · 3 shared drug classes
GlaxoSmithKline · 3 shared drug classes
The University of Hong Kong · 3 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for International Centre for Diarrhoeal Disease Research, Bangladesh:

Cite this brief

Drug Landscape (2026). International Centre for Diarrhoeal Disease Research, Bangladesh — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/international-centre-for-diarrhoeal-disease-research-bangladesh. Accessed 2026-05-17.